Common Variable Immunodeficiency (CVID) and Inclusion Body Myositis (IBM)
- 31 August 2000
- journal article
- case report
- Published by Elsevier in Immunobiology
- Vol. 202 (2) , 199-203
- https://doi.org/10.1016/s0171-2985(00)80067-4
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Mechanism of Intravenous Immune Globulin Therapy in Antibody-Mediated Autoimmune DiseasesNew England Journal of Medicine, 1999
- Controlled Studies with High-Dose Intravenous Immunoglobulin in the Treatment of Dermatomyositis, Inclusion Body Myositis, and PolymyositisNeurology, 1998
- Sporadic inclusion-body myositis and hereditary inclusion-body myopathies: current concepts of diagnosis and pathogenesisCurrent Opinion in Rheumatology, 1998
- Common variable immunodeficiency and inclusion body myositis: A distinct myopathy mediated by natural killer cellsAnnals of Neurology, 1995
- Inclusion Body Myositis: New ConceptsSeminars in Neurology, 1993
- Treatment of inclusion‐body myositis with high‐dose intravenous immunoglobulinNeurology, 1993
- Abnormalities of lymphokine gene expression in patients with common variable immunodeficiency.The Journal of Immunology, 1990
- The role of lymphokines in common variable hypogammaglobulinemiaImmunology Today, 1989
- INCLUSION BODY MYOSITISBrain, 1989
- Clinical and immunologic analyses of 103 patients with common variable immunodeficiencyJournal of Clinical Immunology, 1989